Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Deferred Taxes: 2009-2012

Historic Deferred Taxes for UNITED THERAPEUTICS (UTHR) over the last 3 years, with Sep 2012 value amounting to $30.4 million.

  • UNITED THERAPEUTICS's Deferred Taxes rose 58.03% to $30.4 million in Q3 2012 from the same period last year, while for Sep 2012 it was $113.8 million, marking a year-over-year increase of 88.51%. This contributed to the annual value of $41.9 million for FY2010, which is 4138.82% up from last year.
  • UNITED THERAPEUTICS's Deferred Taxes amounted to $30.4 million in Q3 2012, which was down 1.91% from $31.0 million recorded in Q2 2012.
  • UNITED THERAPEUTICS's 5-year Deferred Taxes high stood at $35.7 million for Q2 2011, and its period low was -$5.0 million during Q4 2010.
  • Its 3-year average for Deferred Taxes is $20.2 million, with a median of $19.2 million in 2010.
  • Over the last 5 years, UNITED THERAPEUTICS's Deferred Taxes had its largest YoY gain of 722.55% in 2010, and its largest YoY loss of 188.60% in 2010.
  • Quarterly analysis of 4 years shows UNITED THERAPEUTICS's Deferred Taxes stood at -$1.7 million in 2009, then tumbled by 188.60% to -$5.0 million in 2010, then grew by 6.82% to $19.2 million in 2011, then spiked by 58.03% to $30.4 million in 2012.
  • Its Deferred Taxes stands at $30.4 million for Q3 2012, versus $31.0 million for Q2 2012 and $33.2 million for Q1 2012.